What is the equivalent Armor Thyroid (desiccated thyroid) dose for a patient previously on 75mcg of Levothyroxine (T4)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 22, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Research

The equivalent Armour Thyroid dose for someone previously taking 75 mcg of levothyroxine would be approximately 45-60 mg (typically starting with 45 mg or 3/4 grain). When switching from levothyroxine to Armour Thyroid, it's essential to understand that Armour contains both T4 (levothyroxine) and T3 (liothyronine) hormones, while levothyroxine contains only T4. The conversion is not exact, but generally, 100 mcg of levothyroxine is roughly equivalent to 60 mg (1 grain) of Armour Thyroid, as supported by a study published in 2021 1.

Key Considerations

  • The transition should be monitored with thyroid function tests after 6-8 weeks to ensure proper dosing.
  • Patients may experience different symptoms during the transition as the body adjusts to receiving both T3 and T4 directly rather than converting T4 to T3 naturally.
  • Take Armour Thyroid in the morning on an empty stomach, at least 30-60 minutes before eating, and separate it from calcium, iron supplements, and certain medications that can interfere with absorption.
  • Some patients may require dose adjustments based on symptoms and lab results, as indicated by a systematic review and meta-analysis published in 2024 2.

Evidence-Based Recommendations

The most recent and highest quality study, published in 2024 2, suggests that combined therapy with T4 and T3, or desiccated thyroid, may lead to higher T3 and lower T4 levels compared to T4 monotherapy in hypothyroidism. However, no significant effects on heart rate, lipid profile, or quality of life were noted. Given the heterogeneity of results, personalized treatment approaches are recommended.

Clinical Implications

In clinical practice, the decision to switch from levothyroxine to Armour Thyroid should be based on individual patient needs and responses to treatment, as supported by a study published in 2021 1. Patients who remain symptomatic on levothyroxine therapy may benefit from a trial of combination therapy with LT4+LT3, as recommended by clinical guidelines 3.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.